| Dr Ronald L Fulkerson, MD PSC | |
|
1300 W Lexington Ave, Winchester, KY 40391 | |
| (859) 744-8003 | |
| (859) 744-2286 |
| Full Name | Dr Ronald L Fulkerson |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1300 W Lexington Ave, Winchester, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407991011 | NPI | - | NPPES |
| 64184179 | Medicaid | KY | |
| 65914350 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 18417 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald L Fulkerson, MD PSC 1300 W Lexington Ave, Winchester, KY 40391 Ph: (859) 744-8003 | Dr Ronald L Fulkerson, MD PSC 1300 W Lexington Ave, Winchester, KY 40391 Ph: (859) 744-8003 |
News Archive
ParaPRO, LLC, announced that researchers have presented data showing the effectiveness of Natroba (spinosad) Topical Suspension, 0.9% against head lice and nits following one treatment without nit combing. Those data about the pediculicide, derived from a naturally-occurring soil bacterium, were presented in a poster session on Saturday, Oct. 15, 2011 at the American Academy of Pediatrics National Conference and Exhibition in Boston.
Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
› Verified 5 days ago
Elizabeth Ann Griffith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1520 Boonesboro Rd, Winchester, KY 40391 Phone: 859-744-0067 | |
Lauren F Kostelnik, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 225 Hospital Dr, Ste 200c, Winchester, KY 40391 Phone: 859-737-6481 Fax: 859-737-6640 | |
Dr. Casey Lane Clark, Pediatrics Medicare: Medicare Enrolled Practice Location: 1850 Bypass Rd, Winchester, KY 40391 Phone: 859-744-5111 Fax: 859-744-1177 | |
Dr. Suzanne Marie Pica, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 505 Shoppers Dr, Suite 2, Winchester, KY 40391 Phone: 859-744-1358 Fax: 859-744-3144 | |
Ralph A. Alvarado, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 25 E Hickman St, Winchester, KY 40391 Phone: 859-556-0620 Fax: 859-744-4997 | |
Eric W. Bradburn, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 475 Shoppers Dr, Winchester, KY 40391 Phone: 859-744-5111 Fax: 859-744-1177 |